National Cerebral and Cardiovascular Center

Osaka 565-8565

1 studies enrolling now · 8 studies all time

What they study most

CTEPH, Chronic Thromboembolic Pulmonary Hypertension, Class I or II Indication for Implantation of a Single Chamber Ventricular Pacemaker According to ACC/AHA/HRS 2001 Guidelines and Any National Guidelines, Heart Failure, Intracerebral Hemorrhage, Stroke, Cardiovascular, Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy, Transthyretin Amyloidosis (ATTR) With Cardiomyopathy

Studies at this site

• MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM) — Recruiting now
• A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) — Running, not enrolling
• TrEatment Approach in the Multimodal Era Registry — Running, not enrolling
• CT (Computerized Tomography) for Late EndovasculAr Reperfusion — Completed
• REDUCE LAP-HF TRIAL II — Running, not enrolling
• International BPA Registry — Completed
• Micra Transcatheter Pacing Study — Completed
• Antihypertensive Treatment of Acute Cerebral Hemorrhage-II — Stopped early